Sukhi Thethy
Comptroller/Controller/Auditor bei CHINOOK THERAPEUTICS, INC.
Aktive Positionen von Sukhi Thethy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Karriereverlauf von Sukhi Thethy
Ehemalige bekannte Positionen von Sukhi Thethy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Ausbildung von Sukhi Thethy
| San Jose State University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Börse
- Insiders
- Sukhi Thethy
- Erfahrung